Kiani A - Search Results

1

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.

Röllig C, Serve H, Hüttmann A, Noppeney R, Müller-Tidow C, Krug U, Baldus CD, Brandts CH, Kunzmann V, Einsele H, Krämer A, Schäfer-Eckart K, Neubauer A, Burchert A, Giagounidis A, Krause SW, Mackensen A, Aulitzky W, Herbst R, Hänel M, Kiani A, Frickhofen N, Kullmer J, Kaiser U, Link H, Geer T, Reichle A, Junghanß C, Repp R, Heits F, Dürk H, Hase J, Klut IM, Illmer T, Bornhäuser M, Schaich M, Parmentier S, Görner M, Thiede C, von Bonin M, Schetelig J, Kramer M, Berdel WE, Ehninger G; Study Alliance Leukaemia. Röllig C, et al. Among authors: kiani a. Lancet Oncol. 2015 Dec;16(16):1691-9. doi: 10.1016/S1470-2045(15)00362-9. Epub 2015 Nov 6. Lancet Oncol. 2015. PMID: 26549589 Clinical Trial.

2

Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment.

Kiani A, Köhne CH, Franz T, Passauer J, Haufe T, Gross P, Ehninger G, Schleyer E. Kiani A, et al. Cancer Chemother Pharmacol. 2003 Mar;51(3):266-70. doi: 10.1007/s00280-003-0574-3. Epub 2003 Mar 4. Cancer Chemother Pharmacol. 2003. PMID: 12655447

3

Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.

Kiani A, Habermann I, Schäke K, Neubauer A, Rogge L, Ehninger G. Kiani A, et al. Haematologica. 2003 Jul;88(7):754-61. Haematologica. 2003. PMID: 12857553

4

Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.

Kiani A, Habermann I, Haase M, Feldmann S, Boxberger S, Sanchez-Fernandez MA, Thiede C, Bornhäuser M, Ehninger G. Kiani A, et al. J Leukoc Biol. 2004 Nov;76(5):1057-65. doi: 10.1189/jlb.0404259. Epub 2004 Aug 3. J Leukoc Biol. 2004. PMID: 15292278

5

Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.

Bornhäuser M, Eger L, Oelschlaegel U, Auffermann-Gretzinger S, Kiani A, Schetelig J, Illmer T, Schaich M, Corbeil D, Thiede C, Ehninger G. Bornhäuser M, et al. Among authors: kiani a. Leukemia. 2005 Jan;19(1):161-5. doi: 10.1038/sj.leu.2403563. Leukemia. 2005. PMID: 15510205 No abstract available.

6

T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.

Schetelig J, Kiani A, Schmitz M, Ehninger G, Bornhäuser M. Schetelig J, et al. Among authors: kiani a. Cancer Immunol Immunother. 2005 Nov;54(11):1043-58. doi: 10.1007/s00262-005-0681-6. Epub 2005 May 11. Cancer Immunol Immunother. 2005. PMID: 15887014 Free PMC article. Review.

7

Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation.

Bornhauser M, Thiede C, Babatz J, Schetelig J, Illmer T, Kiani A, Platzbecker U, Herr W, Rieber EP, Ehninger G, Schmitz M. Bornhauser M, et al. Among authors: kiani a. Leukemia. 2006 Nov;20(11):2055-7. doi: 10.1038/sj.leu.2404383. Epub 2006 Aug 31. Leukemia. 2006. PMID: 16990776 No abstract available.

8

Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.

Pöhlmann C, Schetelig J, Reuner U, Bornhäuser M, Illmer T, Kiani A, Ehninger G, Jacobs E, Rohayem J. Pöhlmann C, et al. Among authors: kiani a. Clin Infect Dis. 2007 Jun 15;44(12):e118-20. doi: 10.1086/518282. Epub 2007 May 2. Clin Infect Dis. 2007. PMID: 17516391

9

Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes.

Kiani A, Kuithan H, Kuithan F, Kyttälä S, Habermann I, Temme A, Bornhäuser M, Ehninger G. Kiani A, et al. Exp Hematol. 2007 May;35(5):757-70. doi: 10.1016/j.exphem.2007.02.001. Exp Hematol. 2007. PMID: 17577925 Free article.

10

Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

Haentzschel I, Freiberg-Richter J, Platzbecker U, Kiani A, Schetelig J, Illmer T, Ehninger G, Schleyer E, Bornhäuser M. Haentzschel I, et al. Among authors: kiani a. Bone Marrow Transplant. 2008 Jul;42(2):113-20. doi: 10.1038/bmt.2008.85. Epub 2008 Mar 24. Bone Marrow Transplant. 2008. PMID: 18362900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page